Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.vistapharmaceuticals.com | |
Market Cap | 50.70 Cr. | |
Enterprise Value(EV) | 59.96 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -1.78 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.54 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 8.35 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 1.28 | Calculated using Price: 10.66 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 4.76 Cr. | 47,564,899 Shares |
FaceValue | 2 | |
About Vista Pharmaceuticals Ltd. | ||
Vista Pharmaceuticals Limited was incorporated on January 25,1991 under the Companies Act of 1956 with the Registrar of Companies Andhra Pradesh & has obtained Certificate of Commencement of Business on February 7, 1991. Vista Pharmaceuticals was incorporated by Dr. Dhananjaya Alli & his associates. The capital was subscribed by Vista Pharmaceuticals Inc., an Overseas Corporate Body promoted by them as a per the laws of State of New Jersy, United States of America. |
1 Day |
|
+3.92% |
1 Week |
|
-4.20% |
1 Month |
|
-20.0% |
3 Month |
|
-26.12% |
6 Month |
|
-37.36% |
1 Year |
|
+30.43% |
2 Year |
|
+21.02% |
5 Year |
|
-41.84% |
10 Year |
|
+245.45% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 13.94 | 7.15 | 8.97 | 10.19 | 3.15 | -11.68 | -6.43 | -2.6 | -17.16 | |
Return on Capital Employed (%) | 14.16 | 9.57 | 8.92 | 12.42 | 6.28 | -5.2 | -5.1 | -3.75 | -9.85 | |
Return on Assets (%) | 7.39 | 3.15 | 3.7 | 4.67 | 1.78 | -7.11 | -3.89 | -1.7 | -10.73 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 10 | 11 | 17 | 32 | 36 | 30 | 33 | 35 | 37 | 39 | |
Non Curr. Liab. | 0 | 8 | 5 | 6 | 6 | 5 | 11 | 4 | 3 | 2 | |
Curr. Liab. | 12 | 7 | 19 | 15 | 11 | 16 | 9 | 13 | 14 | 14 | |
Minority Int. | |||||||||||
Equity & Liab. | 23 | 26 | 41 | 53 | 53 | 51 | 53 | 52 | 53 | 54 | |
Non Curr. Assets | 11 | 10 | 16 | 25 | 29 | 30 | 37 | 29 | 30 | 30 | |
Curr. Assets | 12 | 16 | 26 | 28 | 23 | 21 | 15 | 24 | 24 | 24 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 23 | 26 | 41 | 53 | 53 | 51 | 53 | 52 | 53 | 54 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 14 | 15 | 24 | 29 | 31 | 23 | 1 | 0 | 1 | 8 | |
Other Income | 0 | 0 | 0 | 0 | 3 | 4 | 0 | 0 | 0 | 1 | |
Total Income | 14 | 15 | 24 | 29 | 34 | 27 | 1 | 1 | 1 | 9 | |
Total Expenditure | -11 | -13 | -21 | -24 | -30 | -28 | -3 | -2 | -5 | -13 | |
PBIDT | 3 | 3 | 3 | 6 | 4 | -1 | -2 | -1 | -4 | -5 | |
Interest | 0 | -1 | -1 | -2 | -2 | -2 | -2 | -1 | -1 | -1 | |
Depreciation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -2 | |
Taxation | 0 | 0 | 0 | -1 | 0 | 0 | 2 | 2 | 0 | -1 | |
Exceptional Items | |||||||||||
PAT | 1 | 1 | 1 | 2 | 1 | -4 | -2 | -1 | -6 | -8 | |
Adjusted EPS | 1 | 0 | 0 | 1 | 0 | -1 | -1 | 0 | -2 | -2 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | -4 | -3 | 3 | -5 | 3 | 1 | -7 | -1 | -2 | |
Cash Fr. Inv. | 0 | 0 | 0 | -4 | -11 | -6 | -2 | 0 | 0 | -1 | |
Cash Fr. Finan. | 4 | 3 | 6 | 11 | 1 | 0 | 7 | 1 | 3 | ||
Net Change | 0 | 0 | 5 | -4 | -1 | -1 | 0 | 0 | 0 | ||
Cash & Cash Eqvt | 0 | 0 | 0 | 6 | 2 | 1 | 0 | 0 | 0 | 0 |
Fri, 29 Mar 2024
Closure of Trading Window Closure of Trading Window |
Tue, 13 Feb 2024
Outcome Of Circular Resolutions Passed By Board Of Directors Of The Company By Circulation On 13.02.2024 Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. Circular resolution |
Sat, 10 Feb 2024
Outcome Of Board Meeting Under Regulation 30 Read With 33 (3) (C) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 Board Meeting Outcome |
Thu, 28 Mar 2024 |
High Delivery Percentage |
Closing Below Previous Low |
Closing Below Previous Low for 3 days |
Making Lower Lows for 3 days |
Close Below Last Week Low |